Top court in Massachusetts says companies. (Boston Globe)
is on medical leave and no longer seeing patients, according to a statement released a day after the Los Angeles Times reported that Puliafito “associated with criminals and drug users†during his term as dean at USC’s Keck School of Medicine.
If at first you don't succeed ... repeal. When support for the Senate's repeal and replace Obamacare bill imploded on Monday night, Majority Leader Mitch McConnell (R-Ky.) said the Senate will simply
U.S. neurologist who would like to treat baby Charlie Gard for meetings. (BBC)
Mail processor at a Pennsylvania prison opened a letter and got a . The Pittsburgh Post-Gazette explains why.
Is (KevinMD)
hits Wilmington, N.C.: residents worry about a chemical called GenX discharged from a Du Pont/Chemours facility. (North Carolina Health News)
Big Tobacco sees a growth market in ... wait for it ... for smoking cessation, according to UCSF researchers. (Annals of Internal Medicine, Reuters)
The FDA won't approve the osteoporosis drug romosuzumab, the . Although the firm didn't mention a high rate of adverse events in one of the drug's trials, that was the basis for the rejection.
Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the ľֱ community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.